INFARMED, IP is a Government agency accountable to the Health Ministry, that evaluates, authorises, regulates and controls human medicines as well as health products, namely, medical devices and cosmetics for the protection of Public Health.
AIBILI has a protocol with INFARMED to collaborate in the framework of the national strategy for the development of clinical research in the pharmaceutical sector.
Since 2008 that AIBILI-CHAD has been responsible for a Pharmacovigilance Unit of the National Pharmacovigilance System contracted with INFARMED, IP.